RAMESH SINGA: Open Payments
NPI 1184981805 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,625 in 122 payments from 14 companies in 2025. Trend: 2023 $5,934 · 2024 $5,399 · 2025 $3,625
Food & beverage: $3,025Honoraria: $600
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 46 | $1,483 |
| PROTEGA PHARMACEUTIALS INC | 30 | $1,094 |
| Collegium Pharmaceutical, Inc. | 15 | $238 |
| VERTEX PHARMACEUTICALS INCORPORATED | 6 | $203 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $136 |
| PFIZER INC. | 5 | $87 |
| SPR Therapeutics, Inc | 2 | $81 |
| SI-BONE, INC. | 3 | $81 |
| Stryker Corporation | 1 | $65 |
| Averitas Pharma Inc. | 2 | $46 |
Products named: ROXYBOND, PROCLAIM, ETERNA, JOURNAVX, Belbuca, RELISTOR, XTAMPZA, NURTEC ODT.
Industry payments across TX — which companies pay providers there.
